Objective: The proposed study is focussed at developing acyclovir microemulsions for topical drug delivery systems. QbD was applied for better understanding of the process and to generate design space, using quality target product profile, critical quality attributes, and risk assessment. The aim of the experiment is to prepare a safe, efficacious, stable and patient compliant microemulsion dosage form of Acyclovir. Materials and methods: Pre-formulation studies were carried out which helped in developing a suitable dosage form. UV, FTIR and DSC studies were done for pre-formulation and post-formulation evaluations. QbD was applied to generate design space, using QTPP, CQA, and risk assessment. Microemulsions of acyclovir were developed by using 3 2 factorial designs. Pseudo terneary phase diagrams were constructed to screen various surfactants and co-surfactants for the preparation of microemulsions. Two independent variables Oil Concentration (X1) and Smix Concentration (X2) at three levels low, medium and high were selected and response surface plots were generated. The microemulsions were prepared by plotting pseudo terneary phase diagrams. Various characterizations that were carried out include % transmittance, Viscosity and % drug release. Statistical analyses of batches and surface response studies were done to understand the effect of various independent variables on the dependent variables. Results and Discussions: The λmax was confirmed at 251 nm by UV spectroscopy. The melting point was determined experimentally to be 246 0 C which confirms the drug to be Acyclovir. FTIR and DSC studies confirmed that the drug is Acyclovir. Conclusion: The study indicates that microemulsions of Acyclovir by QbD approach were successfully developed.
INTRODUCTION
Acyclovir is a potent, specific antiviral drug which is active against herpes simplex viruses' types I and II and varicella zoster virus 1 . Acyclovir is available as various dosage forms in the market which includes capsules, creams, ointments, tablets and suspension. Idea of microemulsions was first presented by Hoar and Schulman in 1940s. It is an arrangement of water, oil and surfactant, which is optically isotropic and thermodynamically stable fluid that have low consistency or interfacial film comprising of surfactant/cosurfactant 2 . It is vehicle for enhancing drug delivery, optimization of dose and bioavailability of drugs 3 . It is wellestablished that medium chain unsaturated fats impact tight intersections of epithelial cells, and long chain unsaturated fats allow lipoprotein amalgamation and consequential lymphatic absorption. Lately, various investigations have Quality by design (QbD) is an efficient way to bring quality into both product and process. QbD can be achieved by constructive planning of all the previous data that is accessible. Although it is based on certain amount of risks, it gives results that reduces the risk of end product failure and increases the chances of regulatory acceptance 4 . ICH Q8, ICH Q9 and ICH Q10 do explain the principles of QbD in the best way. They provide guidelines on science and risk based assessment, life cycle of product and various approaches in its development. It is also well known fact that there can be a great deal of unpredictability in scale up of a product from research and development, although the reason for failure is ISSN: 2250-1177
[238] CODEN (USA): JDDTAO not generally understood. QbD is an approach to be applied in all stages of drug discovery, production and delivery [5] [6] .
MATERIALS AND METHODS

Materials
The drug Acyclovir was obtained as gift sample from Aurobindo Pharma, Hyderabad. All other chemicals that were used in the experiment were of the analytical grade.
Methods
Pre-formulation studies
Determination of melting point of Acyclovir:
Melting point of Acyclovir was determined by open capillary method.
Determination of wavelength maxima (λmax) of Acyclovir:
Determination of wavelength maxima (λmax) was done for Acyclovir.
Preparation of calibration curve for Acyclovir:
The calibration curve of Acyclovir was plotted by taking 0.1N HCl as the solvent.
Identification of Acyclovir by FT-IR Spectroscopy:
FTIR study was carried for Acyclovir.
Identification of Acyclovir by DSC Study:
The thermograph of Acyclovir was obtained by DSC.
Screening for components of microemulsion
Most important criterion for screening of component for microemulsion formulation is solubility of the drug in oils, surfactants and co-surfactants. Solubility of Acyclovir in various oils, surfactants and co-surfactants was determined by dissolving excess amount of drug in 2 mL of each selected oils, surfactants and co-surfactants in 5 mL capacity stoppered vials separately and mixed using vortex mixer. Equilibrated samples were removed and centrifuged; the supernatant liquid was taken and filtered through 0.45 µm membrane filter. Concentration of Acyclovir was determined in each component by double beam UV-VIS spectrophotometer at λmax251 nm after appropriate dilution.
Construction of pseudo ternary phase diagram
Pseudoternary phase diagram were constructed using water titration method at ambient temperature (25°C). Surfactant and co-surfactant were in different volume ratios and titrated with water by drop wise under gentle agitation. Proper ratio of one excipient to another in microemulsion formulation was analysed and pseudoternary plot is constructed.
Optimization of oils, surfactants and co-surfactants:
From pseudoternary phase diagrams showing maximum microemulsion region, number of microemulsion with different formula were selected covering entire range of microemulsion occurrence in phase diagram. For each phase diagram constructed, different formulation was selected from microemulsion region so that drug could be incorporated in oil phase on following bases. (a) Oil concentration should be such that it solubilizes drug (single dose) completely depending on solubility of drug in oil. (b) Minimum concentration of Smix used for that amount of oil was taken. (c) For convenience purpose, about 1 mL was selected as microemulsion formulation, so that it can increase or decreased as per requirement in proportions.
Beauty of this system is scale up of proportions is easy, as system is thermodynamically stable.
Formulation and development of Acyclovir microemulsion using Design of experiments [DoE] approach:
A design space can signify formulation and process understanding viz. attributes which are related to drug substance, materials, equipment and finished product quality. For this purpose, risk assessment was done based on understanding process and formulation related parameters on microemulsion quality. Preliminary studies and later Design of Experimentation (DoE) was carried out for high risk parameters. Based on effect of critical quality attributes of target product profile, we proposed design space for obtaining robust formulation. Characterization of microemulsion is done for various parameters like effect of globule size, viscosity, %transmittance, %drug release.
Characterization of acyclovir loaded microemulsion Droplet size analysis:
Droplet size analysis of microemulsion was measured by diffusion method using light-scattering particle size analyser.
Zeta potential:
Zeta potential is measured by instrument known as Zetasizer. It is used to measure charge on surface of droplet in microemulsion.
pH:
pH of formulation is measured by pH meter.
Viscosity determination:
Viscosity of microemulsion is measure by using Brookfieldtype rotary viscometer at different shear rates.
In-vitro drug release studies
Drug release kinetics are studied using modified method glass cup with cross-sectional area of 1.5 cm 2 will fill with 0.2ml of microemulsion, covered with cellophane membrane, sealed with rubber band and adhesive tape, and inverted under surface of 30 ml of phosphate buffer pH in USP XXIII Type I Dissolution Test Apparatus with speed of 30 rpm. Aliquots are withdrawn at specified time intervals and immediately replaced with fresh dissolution medium to maintain sink condition. Drug content in withdrawn samples will be determined spectrophotometrically at 251 nm.
Risk Assessment to identify CQAs affecting drug product quality:
Risk assessments was done to select formulation and process variable which may affect product quality for CQAs by process characterization that defines satisfactory changes in material and process parameters. As a final point, this can result in quality assurance by process design space to understand and develop control strategy. Critical quality attributes were categorized into high, medium and low risk parameters based on knowledge space. Usually high-risk parameters are considered important for Design of Experiments as they are having more effect than others and need to be in accepting multivariate ranges. Effect of different independent variables ( Oil concentration and Smix Concentration) were checked by evaluating % Transmittance, viscosity and % drug release of Acyclovir microemulsion formulated in preliminary trial batches. Based on that characterization, CQAs were selected which have greater effect on microemulsion formulations.
Design of Experimentation (DoE) of Acyclovir microemulsion by using QbD approach:
A design space can signify formulation and process variables that affects attributes which are related to drug substance, materials, equipments and finished product quality. For this purpose, risk assessment was done based on understanding of process and formulation related parameters on microemulsion quality. Preliminary studies and later Design of Experimentation (DoE) was carried out for high risk parameters. Based on effect of critical quality attributes of target product profile, design space for obtaining robust formulation was proposed.
RESULTS AND DISCUSSIONS
Pre-formulation studies
Determination of melting point of Acyclovir:
The melting point of Acyclovir was found to be 246 0 C.
Determination of wavelength maxima (λmax) of Acyclovir:
The wavelength maxima (λmax) of Acyclovir were found to be 251 nm.
Figure 2 Wavelengthmax (λmax) of Acyclovir
Preparation of calibration curve for Acyclovir:
Figure 3 Calibration curve for Acyclovir
Identification of Acyclovir by FT-IR Spectroscopy:
The recorded IR spectrum of Acyclovir is Identification of Acyclovir by DSC Study:
Figure 5: DSC thermograph
Construction of pseudo ternary phase diagram
Pseudo ternary phase diagrams are constructed to identify microemulsion region and suitable composition of oil, surfactant, cosurfactant for formulation of microemulsion. From pseudoternary diagram it was found that system containing of Captex 200 as oily phase, Tween 20 as surfactant and PEG 400 as co-surfactant showed good microemulsifying property at Smix ratio 4:1.it was observed that by increasing oil content, system show appearance of coarse emulsion. It was observed that by increasing cosurfactant in Smix ratio system show decreasing property of spontaneous microemulsion formation. Hence from this observation it is clear that surfactant play key role in formation of microemulsion. Various batches of Acyclovir microemulsion were designed by DoE using QbD approach according to 3 2 factorial designs which are as shown in Table 3 . 
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Compositions of Factorial Batches in Coded Form
Various batches of Acyclovir microemulsions with Eudragit RS 100 were prepared according to 3 2 factorial designs which are as shown in Table 4 .: Characterization of Acyclovir microemulsions batches ACME1-ACME9: 
CONCLUSION
The focus of the current study was to develop topical microemulsion drug delivery system of acyclovir using QbD approach. Pre-formulation studies were carried out which helped in developing a suitable dosage form. UV, FTIR and DSC studies were done for pre-formulation and postformulation evaluations. QbD was applied to generate design space, using QTPP, CQA, and risk assessment. Microemulsions of acyclovir were developed by using 3 2 factorial designs. Pseudo terneary phase diagrams were constructed to screen various surfactants and co-surfactants for the preparation of microemulsions. Two independent variables Oil Concentration (X1) and Smix Concentration (X2) at three levels low, medium and high were selected and response surface plots were generated. The microemulsions were prepared by plotting pseudo terneary phase diagrams. Various characterizations that were carried out include % transmittance, Viscosity and % drug release. Statistical analyses of batches and surface response studies were done to understand the effect of various independent variables on the dependent variables. Lastly it was concluded that microemulsions of Acyclovir using QbD approach were successfully developed.
